OR WAIT null SECS
March 16, 2022
Novasep increases its production capacity for HPAPIs with an investment in its site in Le Mans, France.
EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.
Spectrum Chemical is adding twelve products to its bioCERTIFIED product line.
ProteoGenix’s new XtenCHO Transient Expression can achieve up to ten times higher yields than market-leading CHO systems.
NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.
CDMO Almac Pharma Services expanded its European ultra-low temperature packaging capabilities.
March 15, 2022
The US Congress approved a federal spending package that increases funding for a range of programs to advance health and medicine.
March 14, 2022
Flow Eighteeen38 is receiving a €5 million (US$5.58 million) investment from its parent company, FairJourney Biologics.
Evitria has entered into an agreement with mAbsolve that will allow the company to use mAbsolve’s gene silencing technology in their antibody cells.
March 11, 2022
C4 Therapeutics has been granted orphan drug designation by FDA for CFT8634 for the treatment of soft tissue sarcoma.